The role of stereotactic ablative body radiotherapy in renal cell carcinoma: focus on oligometastatic and oligoprogressive disease

被引：1
作者：
Marandino, Laura [1 ]
Ciccarese, Chiara [2 ]
Francolini, Giulio [3 ]
Amparore, Daniele [4 ]
Campi, Riccardo [5 ,6 ]
机构：
[1] IRCCS San Raffaele Hosp, Dept Med Oncol, Milan, Italy
[2] IRCCS A Gemelli Univ Polyclin Fdn, Comprehens Canc Ctr, Med Oncol, Rome, Italy
[3] Univ Florence, Careggi Univ Hosp, Unit Radiat Oncol, Florence, Italy
[4] Univ Turin, San Luigi Gonzaga Hosp, Sch Med, Dept Oncol,Div Urol, Turin, Italy
[5] Univ Florence, Careggi Hosp, Unit Urol Robot Surg & Renal Transplantat, Florence, Italy
[6] Univ Florence, Dept Expt & Clin Med, Florence, Italy
来源：
MINERVA UROLOGY AND NEPHROLOGY | 2023年 / 75卷 / 02期
关键词：
NEPHRECTOMY;
D O I：
10.23736/S2724-6051.23.05327-2
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：260 / 264
页数：5
相关论文
共 25 条
  • [1] Nivolumab plus ipilimumab (N plus I) vs sunitinib (S) for first-line treatment of advanced renal cell carcinoma (aRCC) in CheckMate 214: 4-year follow-up and subgroup analysis of patients (pts) without nephrectomy
    Albiges, L.
    Tannir, N.
    Burotto, M.
    McDermott, D. F.
    Plimack, E. R.
    Barthelemy, P.
    Porta, C. G.
    Powles, T. B.
    Donskov, F.
    George, S.
    Kollmannsberger, C.
    Gurney, H.
    Grimm, M-O.
    Tomita, Y.
    Castellano Gauna, D.
    Rini, B. I.
    Choueiri, T. K.
    Saggi, S. S.
    McHenry, M. B.
    Motzer, R. J.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S559 - S560
  • [2] The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma
    Ali, Muhammad
    Mooi, Jennifer
    Lawrentschuk, Nathan
    Mckay, Rana R.
    Hannan, Raquibul
    Lo, Simon S.
    Hall, William A.
    Siva, Shankar
    [J]. EUROPEAN UROLOGY, 2022, 82 (06) : 613 - 622
  • [3] Phase III randomized study comparing perioperative nivolumab (nivo) versus observation in patients (Pts) with renal cell carcinoma (RCC) undergoing nephrectomy (PROSPER, ECOG-ACRIN EA8143), a National Clinical Trials Network trial
    Allaf, M.
    Kim, S. E.
    Harshman, L. C.
    McDermott, D. F.
    Master, V. A.
    Signoretti, S.
    Cole, S.
    Moon, H.
    Adra, N.
    Singer, E. A.
    Gills, J.
    Choueiri, T. K.
    Leibovich, B.
    Michaelson, M. D.
    Shuch, B.
    Lara, P. N.
    Heng, D. Y. C.
    Kapoor, A.
    Carducci, M. A.
    Haas, N. B.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1432 - S1433
  • [4] Bex A, 2022, ANN ONCOL, V33, P808
  • [5] Impact of frailty on perioperative and oncologic outcomes in patients undergoing surgery or ablation for renal cancer: a systematic review
    Campi, Riccardo
    Berni, Alessandro
    Amparore, Daniele
    Bertolo, Riccardo
    Capitanio, Umberto
    Carbonara, Umberto
    Erdem, Selcuk
    Ingels, Alexandre
    Kara, Onder
    Klatte, Tobias
    Kriegmair, Maximilian
    Marchioni, Michele
    Minervini, Andrea
    Mir, Maria C.
    Papalia, Rocco
    Pavan, Nicola
    Pecoraro, Angela
    Gomez Rivas, Juan
    Rivasi, Giulia
    Roussel, Eduard
    Ungar, Andrea
    Serni, Sergio
    Esperto, Francesco
    [J]. MINERVA UROLOGY AND NEPHROLOGY, 2022, 74 (02): : 146 - 160
  • [6] Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
    Choueiri, T. K.
    Tomczak, P.
    Park, S. H.
    Venugopal, B.
    Ferguson, T.
    Chang, Y. -H.
    Hajek, J.
    Symeonides, S. N.
    Lee, J. L.
    Sarwar, N.
    Thiery-Vuillemin, A.
    Gross-Goupil, M.
    Mahave, M.
    Haas, N. B.
    Sawrycki, P.
    Gurney, H.
    Chevreau, C.
    Melichar, B.
    Kopyltsov, E.
    Alva, A.
    Burke, J. M.
    Doshi, G.
    Topart, D.
    Oudard, S.
    Hammers, H.
    Kitamura, H.
    Bedke, J.
    Perini, R. F.
    Zhang, P.
    Imai, K.
    Willemann-Rogerio, J.
    Quinn, D. I.
    Powles, T.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (08) : 683 - 694
  • [7] A review of human cell radiosensitivity in vitro
    Deschavanne, PJ
    Fertil, B
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 34 (01): : 251 - 266
  • [8] Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Escudier, B.
    Porta, C.
    Schmidinger, M.
    Rioux-Leclercq, N.
    Bex, A.
    Khoo, V.
    Grunwald, V.
    Gillessen, S.
    Horwich, A.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 (05) : 706 - 720
  • [9] Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience
    Francolini, Giulio
    Campi, Riccardo
    Di Cataldo, Vanessa
    Detti, Beatrice
    Loi, Mauro
    Triggiani, Luca
    La Mattina, Salvatore
    Borghetti, Paolo
    Magrini, Stefano Maria
    Nicosia, Luca
    Alongi, Filippo
    Ghirardelli, Paolo
    Vavassori, Vittorio
    Allegra, Andrea Gaetano
    Aquilano, Michele
    Scoccimarro, Erika
    Peruzzi, Anna
    Pastina, Pierpaolo
    Visani, Luca
    Desideri, Isacco
    Serni, Sergio
    Meattini, Icro
    Livi, Lorenzo
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (10) : 2039 - 2043
  • [10] The evolutionary history of lethal metastatic prostate cancer
    Gundem, Gunes
    Van Loo, Peter
    Kremeyer, Barbara
    Alexandrov, Ludmil B.
    Tubio, Jose M. C.
    Papaemmanuil, Elli
    Brewer, Daniel S.
    Kallio, Heini M. L.
    Hoegnas, Gunilla
    Annala, Matti
    Kivinummi, Kati
    Goody, Victoria
    Latimer, Calli
    O'Meara, Sarah
    Dawson, Kevin J.
    Isaacs, William
    Emmert-Buck, Michael R.
    Nykter, Matti
    Foster, Christopher
    Kote-Jarai, Zsofia
    Easton, Douglas
    Whitaker, Hayley C.
    Neal, David E.
    Cooper, Colin S.
    Eeles, Rosalind A.
    Visakorpi, Tapio
    Campbell, Peter J.
    McDermott, Ultan
    Wedge, David C.
    Bova, G. Steven
    [J]. NATURE, 2015, 520 (7547) : 353 - +
123